ObGyn.net is looking for US-based MDs to share their thoughts on new clinical developments, practice management issues, patient conundrums, regulatory headaches, and more.
ObGyn.net is looking for US-based MDs to share their thoughts on new clinical developments, practice management issues, patient conundrums, regulatory headaches, and more. The content should be directed at physicians, and should have a perspective; we want more than just a rehashing of clinical research, we want you to share your experiences and opinions!
Bloggers are paid, and can contribute weekly, biweekly or monthly. Posts should be between 300-600 words.
Interested? Email us at obgyn@ubm.com.
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
AI helps improve detection of congenital heart defects on prenatal ultrasounds
January 31st 2025AI-assisted software improves clinicians' detection of congenital heart defects in prenatal ultrasounds, enhancing accuracy, confidence, and speed, according to a study presented at SMFM's Annual Pregnancy Meeting.
Read More